ETC

Recommend
Index
  • Daonil Tab.

    Daonil Tab.

    Ingredient

    Glibenclamide

    Content

    5mg

    Indication

    Management of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults

  • Defitelio Inj. 200mg

    Defitelio Inj. 200mg

    Ingredient

    Defibrotide

    Content

    200mg/2.5ml

    Indication

    Treatment of severe hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplant (HSCT).

  • Depakine Chrono Tab. 300mg

    Depakine Chrono Tab. 300mg

    Ingredient

    Sodium Valproate/Valproic Acid

    Content

    300mg

    Indication

    1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
    2) Treatment of manic episodes associated with bipolar disorder
    -In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

  • Depakine Chrono Tab. 500mg

    Depakine Chrono Tab. 500mg

    Ingredient

    Sodium Valproate/Valproic Acid

    Content

    500mg

    Indication

    1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
    2) Treatment of manic episodes associated with bipolar disorder
    -In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

  • Dermatop Ointment/Cream/Soln. 0.25%

    Dermatop Ointment/Cream/Soln. 0.25%

    Ingredient

    Prednicarbate

    Content

    2.5mg/g (Ointment and Cream), 0.25mg/100g (Solution)

    Indication

    Treatment of corticosteroid reactive dermatoses: Eczema, dermatitis (atopic dermatitis, seborrheic dermatitis, allergic contact dermatitis, parapsoriasis, lichen planus, prurigo), and psoriasis

  • Esperson Gel 0.05%

    Esperson Gel 0.05%

    Ingredient

    Desoxymethasone

    Content

    0.5mg/g

    Indication

    Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

  • Esperson Lotion 0.25%

    Esperson Lotion 0.25%

    Ingredient

    Desoxymethasone

    Content

    2.5mg/g

    Indication

    Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

  • Fraxiparine Inj. (Pre-filled)

    Fraxiparine Inj. (Pre-filled)

    Ingredient

    Nadroparin Calcium

    Content

    2850IU/0.3ml, 5700IU/0.6ml

    Indication

    1) Prophylaxis of thromboembolism, especially the prophylaxis of thromboembolism accompanying orthopedic surgery and general surgery
    2) Treatment of deep vein thrombosis (DVT)
    3) Prevention of clotting in extracorporeal circulation during hemodialysis
    4) Treatment of unstable angina and non-Q wave myocardial infarction

  • Handok Relafen Tab.

    Handok Relafen Tab.

    Ingredient

    Nabumetone

    Content

    500mg

    Indication

    Relief of signs and symptoms of osteoarthritis and rheumatoid arthritis

  • Ketas Cap. 10mg

    Ketas Cap. 10mg

    Ingredient

    Ibudilast Granule

    Content

    190mg (10mg as Ibudilast)

    Indication

    Treatment of post stroke dizziness in patients with chronic cerebral circulation disorder associated with a previous cerebral infarction

TOP